By Editorial TeamThe burgeoning landscape of AI in healthcare presents a dual challenge and opportunity for compliance. As regulatory frameworks evolve to address the unique risks of AI, a critical question emerges for both Health IT Professionals and Investors: can established compliance automation platforms, traditionally focused on data privacy and security, effectively pivot to encompass the complexities of AI governance? This week, we examine the strategic moves of key players like Vanta, Drata, and OneTrust as they expand their offerings into AI governance, scrutinizing their capacity to meet the exacting demands of healthcare AI regulatory compliance.
From HIPAA to AI: The Compliance Automation Evolution
The foundational pillars of healthcare data protection, such as the HIPAA Privacy Rule and HIPAA Security Rule, have long driven the need for robust compliance management systems. Companies like Vanta and Drata have built significant market share by automating compliance workflows for standards like SOC 2, streamlining the arduous process of demonstrating adherence to security and privacy controls. Their success has largely been predicated on simplifying the audit readiness process, providing continuous monitoring, and facilitating evidence collection for established regulations. OneTrust, with its broader GRC (Governance, Risk, and Compliance) platform, has traditionally addressed a wider spectrum of privacy and security regulations, including global data protection mandates.
However, the advent of sophisticated AI models in healthcare introduces an entirely new dimension of regulatory complexity. The questions extend beyond data protection to encompass algorithmic fairness, transparency, bias detection, and explainability. This shift necessitates a re-evaluation of what “compliance automation” truly means. The market is witnessing a critical expansion as these established players, alongside specialized AI governance platforms like Credo AI, Holistic AI, Fidd AI, and Arthur AI, vie to define the future of AI compliance. The challenge lies in adapting systems designed for static policy adherence to the dynamic, often opaque, nature of AI systems. This includes not only documenting development and deployment but also continuously monitoring AI performance for drift and unintended consequences, a concern that has been highlighted by ECRI in its hazard rankings for AI in healthcare ECRI AI healthcare hazard rankings.
Navigating the New Regulatory Frontier: EU AI Act and NIST AI RMF 1.0
The regulatory landscape for AI has largely crystallized with the EU AI Act, which was approved in June 2026 and is now in a phased application, with many provisions already in effect and others, including those for high-risk AI systems, set to apply in late 2027 and 2028. The NIST AI Risk Management Framework (AI RMF 1.0), released in January 2023, continues to serve as a prominent voluntary guidepost, with new profiles for generative AI and critical infrastructure released, and the 1.0 version currently undergoing revision. For Health IT Professionals and Investors, understanding how compliance automation platforms address these frameworks is paramount.
Vanta, Drata, and OneTrust are leveraging their existing infrastructure and client relationships to integrate AI governance capabilities. This often involves extending their control libraries to map directly to requirements from the EU AI Act and NIST AI RMF 1.0. For instance, a platform might offer modules for documenting AI system purpose, data provenance, model validation reports, and human-in-the-loop protocols. The ambition is to provide a single pane of glass for both traditional compliance (HIPAA, SOC 2) and emerging AI governance. This integrated approach is particularly appealing to healthcare organizations already burdened by extensive regulatory overhead. The critical difference, however, lies in the depth of AI-specific functionality. While the established players offer a broad stroke, specialized platforms like Credo AI and Holistic AI often provide more granular tooling for AI model risk assessment, bias detection, and continuous monitoring of AI performance metrics. Fidd AI and Arthur AI, with their focus on MLOps and AI observability, offer crucial capabilities for technical validation and ongoing performance tracking, which are integral to demonstrating compliance with evolving AI regulations.
The Human Element in Automated Compliance: A Deven McGraw Perspective
The expansion into AI governance is not merely a technical undertaking; it also requires a deep understanding of ethical and societal implications. Deven McGraw, a recognized authority in health privacy and data policy, has consistently emphasized the need for robust governance frameworks that balance innovation with patient protection. Her insights underscore that compliance is not just about checking boxes but about embedding ethical considerations into the very design and deployment of AI systems. While automation can streamline processes, the fundamental decisions around acceptable risk, fairness, and transparency often require human judgment and expert interpretation. Deven McGraw on AI ethics in healthcare
The challenge for compliance automation platforms is to facilitate this human oversight effectively. This means providing tools that enable clear documentation of design choices, audit trails for model changes, and mechanisms for stakeholder engagement. The HHS OCR is already demonstrating an assertive enforcement posture, including the launch of its Audit Enforcement and Resolution Operation (AERO) in May 2026, which uses AI-powered tools to flag entities for Medicaid enforcement. Furthermore, existing regulations like the Section 1557 rule of the Affordable Care Act, which extends nondiscrimination protections to AI-powered patient care decision support tools, are actively enforced. Therefore, platforms must not only track compliance but also support the narrative of responsible AI development and deployment. This necessitates a blend of automated evidence collection and structured frameworks for human review and decision-making, ensuring that the spirit of regulations like the EU AI Act and the NIST AI RMF 1.0 is upheld, not just the letter.
Strategic Implications for Health IT and Investors
For Health IT Professionals, the expansion of Vanta, Drata, and OneTrust into AI governance represents a potential simplification of their compliance burden. An integrated platform that can manage both HIPAA and AI-specific regulations could reduce vendor sprawl and streamline audit processes. However, a critical evaluation of the depth and maturity of their AI governance features is essential. Are these offerings merely extensions of existing GRC frameworks, or do they incorporate genuine AI-native capabilities for model validation, bias detection, and continuous monitoring? The robust AMA legislative activity around AI oversight has intensified significantly in 2026, with the AMA adopting policies requiring physician oversight of AI and actively supporting federal legislation, such as the ‘Aging with Artificial Intelligence Act’ and bills to combat AI-generated deepfakes.
For Investors and VCs (A1), this market evolution signals significant opportunities and risks. The demand for AI governance solutions is poised for exponential growth as AI adoption in healthcare accelerates and regulatory pressures mount. Investment in specialized AI governance companies like Credo AI, Holistic AI, Fidd AI, and Arthur AI could yield substantial returns, particularly if these platforms demonstrate superior technical capabilities in addressing the nuances of AI risk. Conversely, established compliance automation platforms that successfully pivot and integrate robust AI governance features could solidify their market leadership, offering compelling acquisition targets or partnership opportunities. The ability of any platform to demonstrate proactive readiness for anticipated regulatory shifts, such such as those from the European Commission and NIST, will be a key differentiator. The long-term viability of AI in healthcare hinges not just on technological innovation, but on the ability to navigate a complex and evolving regulatory landscape with confidence and demonstrable compliance. The market is clearly responding, and the next few years will determine which solutions truly become indispensable for healthcare AI’s responsible future.
Frequently Asked Questions
How are established compliance automation platforms like Vanta, Drata, and OneTrust adapting to AI governance in healthcare?
These platforms are expanding their offerings by integrating AI governance capabilities, often extending their control libraries to map to requirements from frameworks like the EU AI Act and NIST AI RMF 1.0. They aim to provide a single platform for both traditional compliance (e.g., HIPAA, SOC 2) and emerging AI governance needs. This involves offering modules for documenting AI system purpose, data provenance, and model validation.
What new complexities does AI introduce to healthcare compliance beyond traditional data protection?
AI introduces new complexities such as algorithmic fairness, transparency, bias detection, and explainability. Compliance now extends beyond static policy adherence to include continuous monitoring of AI performance for drift and unintended consequences. This shift requires adapting systems designed for traditional data protection to the dynamic nature of AI systems.
What are the key regulatory frameworks driving AI governance in healthcare that these platforms are addressing?
The key regulatory frameworks are the EU AI Act, which is in a phased application with provisions for high-risk AI systems applying in late 2027 and 2028, and the NIST AI Risk Management Framework (AI RMF 1.0), a prominent voluntary guidepost. Compliance automation platforms are leveraging these frameworks by integrating their requirements into their control libraries and offerings.
How do specialized AI governance platforms differ from the expanded offerings of Vanta, Drata, and OneTrust?
While Vanta, Drata, and OneTrust offer a broad approach to integrate AI governance with existing compliance, specialized platforms like Credo AI, Holistic AI, Fidd AI, and Arthur AI often provide more granular AI-specific functionality. These specialized platforms focus on areas such as AI model risk assessment, bias detection, continuous monitoring of AI performance metrics, MLOps, and AI observability.
